Multiple sclerosis relapse resolution with corticosteroid alternatives: a retrospective claims analysis of us health plan data

被引：0
|
作者：
Nazareth, T. [1 ]
Zhang, X. [2 ]
Yu, T. -C. [1 ]
Gu, T. [2 ]
Deshpande, G. [2 ]
Mahler, N. [1 ]
Waltrip, R. [1 ]
Tan, H. [2 ]
机构：
[1] Mallinckrodt Pharmaceut, Bedminster, NJ USA
[2] HealthCore Inc, Wilmington, DE USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1594
引用
收藏
页码：900 / 901
页数：2
相关论文
共 50 条
  • [1] Multiple Sclerosis Relapse Rates and Healthcare Costs with Generic Glatiramer Acetate: A Retrospective Claims Analysis of US Health Plan Data
    Kantor, Daniel
    Grabner, Michael
    Zhang, Xian
    Balu, Sanjeev
    Hall, Steven
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 76 - 76
  • [2] Multiple Sclerosis (MS) Relapse Rates and Healthcare Costs with Generic Glatiramer Acetate: a Retrospective Claims Analysis of US Health Plan Data
    Hall, Steven
    Balu, Sanjeev
    Grabner, Michael
    Zhang, Xiam
    Kantor, Daniel
    NEUROLOGY, 2019, 92 (15)
  • [3] Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
    Tara Nazareth
    Manasi Datar
    Tzy-Chyi Yu
    Neurology and Therapy, 2019, 8 : 383 - 395
  • [4] Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
    Nazareth, Tara
    Datar, Manasi
    Yu, Tzy-Chyi
    NEUROLOGY AND THERAPY, 2019, 8 (02) : 383 - 395
  • [5] A RETROSPECTIVE CLAIMS ANALYSIS OF US HEALTH PLAN COMMERCIAL INSURANCE DATA ASSESSING HEALTHCARE COSTS AND RELAPSE RATES IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH GENERIC GLATIRAMER ACETATE
    Greenberg, B.
    Grabner, M.
    Zhang, X.
    Balu, S.
    Hall, S.
    Kantor, D.
    VALUE IN HEALTH, 2019, 22 : S272 - S272
  • [6] Relapse resolution and HCRU in patients with multiple sclerosis: a retrospective study of relapse therapy alternatives to corticosteroids
    Nazareth, T.
    Sheer, R.
    Datar, M.
    Schwab, P.
    Yu, T-C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 750 - 751
  • [7] Multiple Sclerosis Relapse Rates, Before, During, and After Pregnancy: a US Retrospective Claims Database Analysis
    Phillips, Amy L.
    Houtchens, Maria K.
    Edwards, Natalie C.
    NEUROLOGY, 2017, 88
  • [8] MS relapse treatments and relapse resolution: retrospective study results from a US health plan
    Nazareth, T.
    Datar, M.
    Sheer, R.
    Yu, T. -C.
    Schwab, P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 416 - 417
  • [9] Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis
    Bergvall, Niklas
    Makin, Charles
    Lahoz, Raquel
    Agashivala, Neetu
    Pradhan, Ashish
    Capkun, Gorana
    Petrilla, Allison
    Karkare, Swapna U.
    McGuiness, Catherine Balderston
    Korn, Jonathan R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (12) : 1647 - 1656
  • [10] Identifying disability level in multiple sclerosis patients in a US-based health plan claims database
    Berkovich, R.
    Fox, E.
    Okai, A.
    Ding, Y.
    Gorritz, M.
    Bartolome, L.
    Wade, R. L.
    Su, W.
    Russo, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 113 - 114
12345